Multimodality Treatment of Hepatic Metastases

  • Karl Heinrich Link
  • Volker Apell
  • Matthias Holtappels
  • Karim Zayed
  • Tolga Atilla Sagban
  • Matthias Mörschel
  • Thomas Friedrich Weigel
  • Klaus Tischbirek
  • Klaus Maria Josten
  • Ralf Thimm
  • Ludger Staib
Part of the Medical Radiology book series (MEDRAD)


Liver Metastasis Hepatic Resection Median Survival Time Hepatic Metastasis Colorectal Liver Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adam R (2003) Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol 14:13–16CrossRefGoogle Scholar
  2. Adam R, Bismuth H, Castaing D, et al (1997) Repeat hepatectomy for colorectal liver metastases. Ann Surg 225:51–62PubMedGoogle Scholar
  3. Adam R, Avisar E, Ariche A, et al (2001) Five-year survival following hepatic resection after neoadjuvant therapy for non-resectable colorectal. Ann Surg Oncol 8:347–353PubMedGoogle Scholar
  4. Adam R, Pascal G, Azoulay D, et al (2003) Liver resection for colorectal metastases: the third hepatectomy. Ann Surg 238:871–884PubMedGoogle Scholar
  5. Adson MA, van Heerden JA, Adson MH, et al (1984) Resection of hepatic metastases from colorectal cancer. Arch Surg 119:647–651PubMedGoogle Scholar
  6. Advanced Colorectal Cancer Meta-Analysis Project (1992) Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10:896–903Google Scholar
  7. Allen-Mersh TG, Earlam S, Fordy C, et al (1994) Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 344:1255–1260PubMedGoogle Scholar
  8. August DA, Sugarbaker PH, Ottow RT (1985) Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-FU via Tenckhoff catheter on survival. Ann Surg 201:210–218PubMedGoogle Scholar
  9. Azoulay D, Adam R, Castaing D, et al (2001) Multistage liver resections in colorectal liver metastases. The Paul Brousse concept. Chirurg 72:765–769CrossRefPubMedGoogle Scholar
  10. Baker J, Bleiberg H, Hutchison G, et al (1997) An international multidisciplinary approach to the management of advanced colorectal cancer. Eur J Surg Oncol 23:1–66Google Scholar
  11. Ballantyne GH, Quin J (1993) Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 71:4252–4256PubMedGoogle Scholar
  12. Beckurts KT, Holscher AH, Thorban S, et al (1997) Significance of lymphnode involvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg 84:1081–1084CrossRefPubMedGoogle Scholar
  13. Belghiti J, Hiramatsu K, Benoist S, et al (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38–46CrossRefPubMedGoogle Scholar
  14. Bengmark S, Hafstrom L, Jeppsson B (1982) Metastatic disease in the liver from colorectal cancer: An appraisal of liver surgery. World J Surg 6:61–65PubMedGoogle Scholar
  15. Benotti P, Steele G (1992) Patterns of recurrent colorectal cancer and recovery surgery. Cancer 70:1409–1413PubMedGoogle Scholar
  16. Bismuth H, Adam R, Levi F, et al (1996) Resection of non-resectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509–522PubMedGoogle Scholar
  17. Bleicher RJ, Allegra DP, Nora DT, et al (2003) Radiofrequency Liver ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 10:52–58CrossRefPubMedGoogle Scholar
  18. Blumgart LH, Fong Y (1995) Surgical options in the treatment of hepatic metastasis from colorectal cancer. Curr Probl Surg 32:333–421PubMedGoogle Scholar
  19. Bozzetti F, Cozzaglio L, Boracchi P, et al (1993) Comparing surgical resection of limited hepatic metastases from colorectal cancer to non-operative treatment. Eur J Surg Oncol 19:162–167PubMedGoogle Scholar
  20. Butler J, Attiyeh FF, Daly JM (1986) Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet 162:109–113PubMedGoogle Scholar
  21. Cady B, McDermott WV (1985) Major hepatic resection for metachronous metastases from colon cancer. Ann Surg 201:204–209PubMedGoogle Scholar
  22. Christoforidis D, Martinet O, Lejeune FJ, et al (2002) Isolated liver perfusion for non-resectable liver tumours: a review. Eur J Surg Oncol 28:875–890CrossRefPubMedGoogle Scholar
  23. Conlon R, Jacobs M, Dasgupta D, et al (2003) The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur J Ultrasound 16:211–216CrossRefPubMedGoogle Scholar
  24. Desai DC, Zervos EE, Arnold MW, et al (2003) Positron emission tomography affects surgical management in recurrent colorectal cancer patients. Ann Surg Oncol 10:59–64CrossRefPubMedGoogle Scholar
  25. Doci R, Gennari L, Bignami P, et al (1991) One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 78:797–801PubMedGoogle Scholar
  26. Doci R, Gennari L, Bignami P, et al (1995) Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg 82:377–381PubMedGoogle Scholar
  27. Douillard JY, Cunningham D, Roth AD, et al (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicenter randomised trial. Lancet 355:1041–1047CrossRefPubMedGoogle Scholar
  28. Eder M, Weiss M (1991) Hämatogene Lebermetastasen — humanpathologische Grundlagen. Chirurg 62:705–709pPubMedGoogle Scholar
  29. Elias D, Lasser P, Hoang JM, et al (1993) Repeat hepatectomy for cancer. Br J Surg 80:1557–1562PubMedGoogle Scholar
  30. Elias D, Lasser P, Rougier P, et al (1995) Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg 180:213–219PubMedGoogle Scholar
  31. Elias D, Saric J, Jaeck D, et al (1996) Prospective study of microscopic lymph node involvement of the hepatic pedicle during curative hepatectomy for colorectal metastases. Br J Surg 83:942–945PubMedGoogle Scholar
  32. Elias D, Lasser P, Ducreux M, et al (2003a) Liver resection (and associated extrahepatic resections) for metastatic well differentiated endocrine tumors: a 15-year single center prospective study. Surgery 133:375–382CrossRefPubMedGoogle Scholar
  33. Elias D, Ouellet JF, Bellon N, et al (2003b) Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 90:567–574CrossRefPubMedGoogle Scholar
  34. Ercolani G, Grazi GL, Ravaioli M, et al (2002) Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival. Arch Surg 137:1187–1192PubMedGoogle Scholar
  35. Ercolani G, Grazi GL, Ravaioli M, et al (2004) The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg 239:202–209PubMedGoogle Scholar
  36. Evrard S, Becouarn Y, Fonck M, et al (2004) Surgical treatment of liver metastases by radiofrequency ablation, resection, or in combination. Eur J Surg Oncol 30:399–406CrossRefPubMedGoogle Scholar
  37. Fernandez-Trigo V, Shamsa F, Sugarbaker PH (1995) Repeat liver resection from colorectal metastases. Repeat Hepatic Metastases Registry. Surgery 117:296–304PubMedGoogle Scholar
  38. Finlay IG, Meek D, Brunton F, et al (1988) Growth rate of hepatic metastases in colorectal carcinoma. Br J Surg 75:641–644PubMedGoogle Scholar
  39. Formentini A, Link KH, Pillasch J, et al (1997) Neoadjuvant regional chemotherapy for non-resectable pancreatic and hepatic tumors. Int J Oncol (S1)Google Scholar
  40. Fortner JG, Silva JS, Golbey RB (1984) Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I Treatment by hepatic resection. Ann Surg 199:306–316PubMedGoogle Scholar
  41. Foster JH, Lundy J (1981) Liver metastases. Curr Probl Surg 18:157–202PubMedGoogle Scholar
  42. Fowler WC, Eisenberg BL, Hoffman JP (1992) Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma. J Surg Oncol 51:122–125PubMedGoogle Scholar
  43. Fujimoto S, Miyazaki M, Kitsukawa Y, et al (1985) Long-term survivors of colorectal cancer with unresectable hepatic metastases. Dis Colon Rectum 28:588–591PubMedGoogle Scholar
  44. Fujita S, Miyake H, Akasu T, et al (1998) Hepatic arterial infusion (HAI) of 5-FU for unresectable liver metastases from colorectal cancer. J Jpn Soc Coloproctol 51:974Google Scholar
  45. Gansauge F, Link KH, Büchler M, et al (1993) Split-time resection of ‘unresectable’ colorectal liver metastases supported by chemosensitivity directed hepatic artery infusion. International Conference on Regional Cancer Treatment (ICTCT 93). Wiesbaden, 12–14 July 1993Google Scholar
  46. Gennari L, Doci R, Bozzetti F, et al (1986a) Surgical treatment of hepatic metastases from colorectal cancer. Ann Surg 203:49–54PubMedGoogle Scholar
  47. Gennari L, Doci R, Bozzetti F, et al (1986b) Proposal for staging liver metastases. Recent Res Cancer Res 100:80–84Google Scholar
  48. Geoghegan JG, Scheele J (1999) Treatment of colorectal liver metastases. Br J Surg 86:158–169PubMedGoogle Scholar
  49. Germer CT, Isbert C, Albrecht D, et al (1999) Laser-induced thermotherapy combined with hepatic arterial embolization in the treatment of liver tumors in a rat tumor model. Ann Surg 230:55–62CrossRefPubMedGoogle Scholar
  50. Gervaz P, Pakart R, Nivatvongs S, et al (2003) Colorectal adenocarcinoma in cirrhotic patients. J Am Coll Surg 196:874–879CrossRefPubMedGoogle Scholar
  51. Giacchetti S, Itzhaki M, Gruia G, et al (1999) Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 10:663–669CrossRefPubMedGoogle Scholar
  52. Giacchetti S, Perpoint B, Zidani R, et al (2000) Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18:136–147PubMedGoogle Scholar
  53. Gigot JF, Glineur D, Santiago AJ, et al (2002) Laparoscopic liver resection for malignant liver tumors: preliminary results of a multicenter European study. Ann Surg 236:90–97CrossRefPubMedGoogle Scholar
  54. Gillams AR, Lees WR (2000) Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum 43:656–661CrossRefPubMedGoogle Scholar
  55. Gough DB, Donohue JH, Trastek VA, et al (1994) Resection of hepatic and pulmonary metastases in patients with colorectal cancer. Br J Surg 81:94–96PubMedGoogle Scholar
  56. Gouillat C, Ducerf C, Partensky C, et al (1993) Repeated hepatic resections for colorectal metastases. Eur J Surg Oncol 19:443–447PubMedGoogle Scholar
  57. Harmon KE, Ryan JA Jr, Biehl TR, et al (1999) Benefits and safety of hepatic resection for colorectal metastases. Am J Surg 177:402–404CrossRefPubMedGoogle Scholar
  58. Hemming AW, Reed AI, Howard RJ, et al (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237:686–693CrossRefPubMedGoogle Scholar
  59. Herfarth C, Heuschen UA, Lamade W, et al (1995). Rezidiv-Resektionen an der Leber bei primären und sekundären Lebermalignomen. Chirurg 66:949–958PubMedGoogle Scholar
  60. Hermanek P (2000) Qualitätssicherung in der Onkologie: Kurzgefasste interdisziplinäre Leitlinien 2000. Zuckschwerdt Verlag, München, pp 182–188Google Scholar
  61. Hodgson WJ, Friedland M, Ahmed T, et al (1986) Treatment of colorectal hepatic metastases by intrahepatic chemotherapy alone or as an adjuvant to complete or partial removal of metastatic disease. Ann Surg 203:420–425PubMedGoogle Scholar
  62. Hohn DC, Shea WJ, Gemlo BT, et al (1988) Complications and toxicities of hepatic arterial chemotherapy. Contr Oncol 29:169–180Google Scholar
  63. Hughes KS, Sugarbaker PH (1987) Resection of the liver for metastatic solid tumors. In: Rosenberg SA (ed) Surgical treatment of metastatic cancer. Lippincott, Philadelphia, pp 125–164Google Scholar
  64. Hughes KS, Simon R, Songhorabodi S, et al (1986) Resection of the liver for colorectal carcinoma metastases: a multi institutional study of indications for resection. Surgery 100:278–284PubMedGoogle Scholar
  65. Hunt TM, Carty N, Johnson CD (1990) Resection of liver metastases from a colorectal carcinoma does not benefit the patient. Ann R Coll Surg Engl 72:199–205PubMedGoogle Scholar
  66. Imamura H, Sano K, Harihara Y, et al (2003) Complete remission of disease for 5 years following initial and repeat resection of the liver for the removal of 22 metastases of colorectal origin. J Hepatobiliary Pancreat Surg 10:321–324CrossRefPubMedGoogle Scholar
  67. ISTO (2004) Informationszentrum für Standards in der Onkologie. Kurzgefasste Interdisziplinäre Leitlinien 2004. Deutsche Krebsgesellschaft e.V. 2004. Qualitätssicherung in der Onkologie, Diagnostik und Therapie maligner Erkrankugen. W. Zuckschwerdt Verlag, MunichGoogle Scholar
  68. Iwatsuki S, Esquivel C, Gordon RD, et al (1986) Liver resection for metastatic colorectal cancer. Surgery 100:804–810PubMedGoogle Scholar
  69. Jaeck D (2003) The significance of hepatic pedicle lymph node metastases in surgical management of colorectal liver metastases and of other liver malignancies. Ann Surg Oncol 10:1007–1011CrossRefPubMedGoogle Scholar
  70. Jonker D, Maroun J, Kocha W (2000) Survival benefit of chemotherapy in metastatic colorectal cancer: a metaanalysis of randomized controlled trials. Br J Cancer 82:1789–1794CrossRefPubMedGoogle Scholar
  71. Jourdan JL, Cannan R, Stubbs R (1999) Hepatic resection for metastases in colorectal carcinoma. N Z Med J 112:91–93PubMedGoogle Scholar
  72. Kato T, Yasui K, Hirai T, et al (2003) Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum 46:S22–S31PubMedGoogle Scholar
  73. Kemeny N, Conti JA, Cohen A, et al (1994) Phase II study of hepatic arterial floxuridine, leucovorin and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 12:2288–2295PubMedGoogle Scholar
  74. Kemeny N, Huang Y, Cohen AM, et al (1999) Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341:2039–2048CrossRefPubMedGoogle Scholar
  75. Kemeny N, Gonen M, Sullivan D, et al (2001) Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 19:2687–2695PubMedGoogle Scholar
  76. Kemeny MM, Adak S, Gray B, et al (2002) Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy: an intergroup study. J Clin Oncol 20:1499–1505CrossRefPubMedGoogle Scholar
  77. Kemeny N, Jarnagin W, Gonen M, et al (2003) Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol 21:3303–3309PubMedGoogle Scholar
  78. Kern W, Beckert B, Lang N, et al (2001) Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer. Ann Oncol 12:599–603CrossRefPubMedGoogle Scholar
  79. Köckerling F, Scheele J, Schneider C, et al (1991) Chirurgische Therapie von Lebermetastasen bei Karzinoidtumoren. In: Herfarth Ch, Schlag P (eds) Neue Entwicklungen in der Therapie von Lebermetastasen. Springer, Berlin, pp 345–352Google Scholar
  80. Kooby DA, Stockman J, Ben-Porat L, et al (2003) Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 237:860–869PubMedGoogle Scholar
  81. Kornmann M, Link KH (2002) Conversion of locally inoperable primary rectal cancer with multiple liver metastases to an option for cure after local down-staging and hepatic arterial infusion chemotherapy. Langenbecks Arch Surg 387:90–93PubMedGoogle Scholar
  82. Kornmann M, Link KH, Lenz HJ, et al (1997) Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy. Cancer Lett 118:29–35CrossRefPubMedGoogle Scholar
  83. Kornmann M, Butzer U, Blatter J, et al (2000) Preclinical evaluation of the activity of gemcitabine as a basis for regional chemotherapy of pancreatic and colorectal cancer. Eur J Surg Oncol 26:583–587CrossRefPubMedGoogle Scholar
  84. Lamadé W, Hohenberger P, Hinz U, et al (1994) Hepatic reresection for recurrent liver metastases from colorectal cancer. Eur J Surg Oncol 20:317Google Scholar
  85. Langer B, Bleiberg H, Labianca R, et al (2002) Fluorouracil (FU) + I-Feucovorin (I-LV) versus observation after potentially curative resection of liver metastases from colorectal cancer (CRC): Results of the ENG (EORTC/NCIC CTG/GIVIO) randomized trial. Proc Am Soc Oncol 21:A592Google Scholar
  86. Laurent C, Sa Cunha A, Couderc P, et al (2003) Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 90:1131–1136CrossRefPubMedGoogle Scholar
  87. Lehnert T, Otto G, Herfarth C (1995) Therapeutic modalities and prognostic factors for primary and secondary liver tumors. World J Surg 19:252–263CrossRefPubMedGoogle Scholar
  88. Lehnert T, Knaebel HP, Dück M, et al (1999) Sequential hepatic and pulmonary resections for metastatic colorectal cancer. Br J Surg 86:241–243PubMedGoogle Scholar
  89. Lencioni R, Vignali C, Caramella D, et al (1994) Transcatheter arterial embolization followed by percutaneous ethanol injection in the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol 17:70–75CrossRefPubMedGoogle Scholar
  90. Lencioni R, Goletti O, Armillotta N, et al (1998) Radiofrequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial. Eur Radiol 8:1205–1211PubMedGoogle Scholar
  91. Leslie KA, Rossi R, Hughes K, et al (1995) Survival expectancy of patients alive 5 years after hepatic resection for metastatic colon carcinoma: report from the registry of hepatic metastases. Proc Am Soc Oncol 14:200Google Scholar
  92. Leyvraz S, Spataro V, Bauer J, et al (1997) Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol 15:2589–2595PubMedGoogle Scholar
  93. Link KH (1998) Chirurgisch-onkologische Therapie von Mammakarzinom-Lebermetastasen. In: Kreienberg R, Möbus V, Alt D (eds) Management des Mammakarzinoms. Springer, Berlin, pp 274–287Google Scholar
  94. Link KH (2000) Adjuvante Therapie bei Kolon-und Rektumkarzinomen: Zwischenergebnisse einer prospektiven, randomisierten Multicenterstudie (FOGT 1+2). 2/6-05-2000.117. Kongress der Deutschen Gesellschaft für Chirurgie, BerlinGoogle Scholar
  95. Link KH, Aigner KR, Kuehn W, et al (1986) Prospective correlative chemosensitivity testing in high-dose intraarterial chemotherapy for liver metastases. Cancer Res 46:4837–4848PubMedGoogle Scholar
  96. Link KH, Kreuser ED, Safi F, et al (1993) Die intraarterielle Chemotherapie mit 5-FU und Folinsäure (FA, Rescuvolin) im Therapiekonzept bei nicht resektablen kolorektalen Lebermetastasen. Tumordiagnostik Therapie 14:224–231Google Scholar
  97. Link KH, Kornmann M, Safi F, et al (1994) Response prediction in hepatic artery infusion with Fluoropyrimidines using cell culture and polymerase chain reaction techniques. Eur J Surg Oncol 20:317–318Google Scholar
  98. Link KH, Kornmann M, Leder GH, et al (1996) Regional chemotherapy directed by individual chemosensitivity testing in vitro: a prospective decision aiding trial. Clin Cancer Res 2:1469–1474PubMedGoogle Scholar
  99. Link KH, Staib L, Kreuser ED, et al (1996) Adjuvant treatment of colon and rectal cancer: Impact of chemotherapy, radiotherapy and immunotherapy on routine postsurgical patient management. Recent Res Cancer Res 142:311–352Google Scholar
  100. Link KH, Leder G, Pillasch J, et al (1998) In vitro concentration response studies and in vitro phase II tests as the experimental basis for regional chemotherapeutic protocols. Semin Surg Oncol 14:189–201CrossRefPubMedGoogle Scholar
  101. Link KH, Pillasch J, Formentini A, et al (1999a) Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases. Eur J Surg Oncol 25:381–388CrossRefPubMedGoogle Scholar
  102. Link KH, Kornmann M, Formentini A, et al (1999b) Regional chemotherapy of non-resectable liver metastases from colorectal cancer — literature and institutional review. Langenbecks Arch Surg 384:344–353CrossRefPubMedGoogle Scholar
  103. Link KH, Germer CT, Seifert JK, et al (2000a) Neue Wirkprinzipien in der chirurgischen Onkologie. Onkologie 5:450–457Google Scholar
  104. Link KH, Kornmann M, Butzer U, et al (2000b) Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated non-resectable liver tumors receiving hepatic arterial infusion chemotherapy. Cancer 89:288–296CrossRefPubMedGoogle Scholar
  105. Link KH, Sunelaitis E, Kornmann M, et al (2001) Regional chemotherapy of non-resectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival. Cancer 92:2746–2753PubMedGoogle Scholar
  106. Liu CL, Fan ST, Lo CM, et al (2002) Hepatic resection for colorectal liver metastases: prospective study. Hong Kong Med J 8:329–333PubMedGoogle Scholar
  107. Livraghi T, Solbiati L, Meloni F, et al (2003) Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the “test-of-time approach”. Cancer 97:3027–3035CrossRefPubMedGoogle Scholar
  108. Lorenz M, Muller HH (2000) Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with non-resectable liver metastases from colorectal carcinoma. J Clin Oncol 18:243–254PubMedGoogle Scholar
  109. Lorenz M, Müller HH, Staib-Sebler E, et al (1997) Standard/studies for regional treatment of colorectal metastases (ALM study). Eighth International Conference of Regional Cancer Treatment. Reg Cancer Treat (S)72Google Scholar
  110. Lorenz M, Muller HH, Schramm H, et al (1998) Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 228:756–762CrossRefPubMedGoogle Scholar
  111. Mala T, Bohler G, Mathisen O, et al (2002) Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg 26:1348–1353CrossRefPubMedGoogle Scholar
  112. Maruo H, Kosaka A (1994) Evaluation of cases of metastatic liver tumors resected following intra-arterial infusion chemotherapy. Gan To Kagaku Ryoho 21:2143–2146PubMedGoogle Scholar
  113. Meta-analysis Group in Cancer (1996) Reappraisal of hepatic arterial infusion in the treatment of non-resectable liver metastases from colorectal cancer. J Natl Cancer Inst 88:252–258Google Scholar
  114. Meta-analysis Group in Cancer (1998) Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 16:301–318Google Scholar
  115. Murata S, Morya Y, Akasu T, et al (1998) Resection of both hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer 83:1086–1093CrossRefPubMedGoogle Scholar
  116. Nakamura S, Suzuki S, Baba S (1997) Resection of liver metastases of colorectal carcinoma. World J Surg 21:741–747CrossRefPubMedGoogle Scholar
  117. Nordic Gastrointestinal Tumor Adjuvant Therapy Group (1992) Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol 10:904–911Google Scholar
  118. Nordlinger B, Jaeck D, Guiguet M, et al (1992) Surgical resection of hepatic metastases: multicentric retrospective study by the French Association of Surgery. In: Nordlinger B, Jaeck D (eds) Treatment of hepatic metastases of colorectal cancer. Springer, New York, pp 129–161Google Scholar
  119. Nordlinger B, Guiguet M, Vaillant JC, et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77:1254–1262CrossRefPubMedGoogle Scholar
  120. Ochiai T, Sasako M, Mizuno S, et al (1994) Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg 81:1175–1178PubMedGoogle Scholar
  121. O’Connell MJ, Adson MA, Schutt AJ, et al (1985) Clinical trial adjuvant therapy after surgical resection of colorectal cancer metastatic to the liver. Mayo Clin Proc 60:517–520PubMedGoogle Scholar
  122. Ohlsson B, Stenram U, Tranberg KG (1998) Resection of colorectal liver metastases: 25-year experience. World J Surg 22:268–277CrossRefPubMedGoogle Scholar
  123. Oldhafer KJ, Lang H, Malago M, et al (2001) Ex situ Resektion und Resektion an der in situ perfundierten Leber — Gibt es noch Indikationen? Chirurg 72:131–137CrossRefPubMedGoogle Scholar
  124. Onaitis M, Morse M, Hurwitz H, et al (2003) Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases. Ann Surg 237:782–789CrossRefPubMedGoogle Scholar
  125. Oshowo A, Gillams A, Harrison E, et al (2003) Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 90:1240–1243CrossRefPubMedGoogle Scholar
  126. Patt YZ, McBride CM, Ames FC, et al (1987) Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver. Cancer 59:867–873PubMedGoogle Scholar
  127. Pawlik TM, Izzo F, Cohen DS, et al (2003) Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol. 10:1059–1069CrossRefPubMedGoogle Scholar
  128. Petrelli NJ, Nambisan RN, Herrera L (1985) Hepatic resection for isolated metastasis from colorectal carcinoma. Am J Surg 149:205–209PubMedGoogle Scholar
  129. Portier G, Rougier PJ, Milan C, et al (2002) Adjuvant systemic chemotherapy (CT) using 5-fluorouracil (FU) and folinic acid (AA) after resection of liver metastases (LM) from colorectal (CRC) origin. Results of an intergroup phase III study (Trial FFCD — ACHBT — AURC 9002). Proc Proc Am Soc Oncol 21:133aGoogle Scholar
  130. Rau HG, Schauer R, Pickelmann S, et al (2001) Dissektionstechniken in der Leberchirurgie. Chirurg 72:105–112CrossRefPubMedGoogle Scholar
  131. Rivoire M, De Cian F, Meeus P, et al (2002) Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma. Cancer 95:2283–2292CrossRefPubMedGoogle Scholar
  132. Robinson BJ, Rice TW, Strong SA, et al (1999) Is resection of pulmonary and hepatic metastases warranted in patients with colorectal cancer? J Thorac Cardiovasc Surg 117:66–76PubMedGoogle Scholar
  133. Rougier P, Neoptolemos JP (1997) The need for a multidisciplinary approach in the treatment of advanced colorectal cancer: a critical review from a medical oncologist and surgeon. Eur J Surg Oncol 23:385–396CrossRefPubMedGoogle Scholar
  134. Rougier P, Laplanche A, Huguier M, et al (1992) Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 10:1112–1118PubMedGoogle Scholar
  135. Sadahiro S, Suzuki T, Ishikawa K, et al (2004) Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma: a randomized control trial. Cancer 100:590–597CrossRefPubMedGoogle Scholar
  136. Saltz LB, Locker PK, Pirotta N, et al (2000) Weekly irinotecan (CPT-11) leucovorin (LV), and fluorouracil (FU) is superior to daily ×5LV/FU in patients (pts) with previously untreated metastatic colorectal cancer (CRC). Proc Am Soc Clin Oncol 18:898 AbstractGoogle Scholar
  137. Saw RP, Koorey D, Painter D, et al (2002) p53, DCC and thymidylate synthase as predictors of survival after resection of hepatic metastases from colorectal cancer. Br J Surg 89:1409–1415CrossRefPubMedGoogle Scholar
  138. Scaife CL, Curley SA, Izzo F, et al (2003) Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer. Ann Surg Oncol 10:348–354CrossRefPubMedGoogle Scholar
  139. Scheele J (1989) Die segmentorientierte Leberresektion. Grundlagen — Technik — Stellenwert. Chirurg 60:251–265PubMedGoogle Scholar
  140. Scheele J (2001) Anatomical and atypical liver resections. Chirurg 72:113–124CrossRefPubMedGoogle Scholar
  141. Scheele J, Stangl R, Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77:1241–1246PubMedGoogle Scholar
  142. Scheele J, Stangl R, Altendorf-Hofmann A (1994) Repeated hepatic resection for colorectal liver metastases. Eur J Surg Oncol 20:315–316Google Scholar
  143. Scheele J, Altendorf-Hofmann A, Stangl R, et al (1996) Chirurgische Resektion kolorektaler Lebermetastasen: Goldstandard für solitäre und radikal resektable Herde. Swiss Surg (S4):4–17Google Scholar
  144. Scheithauer W, Rosen H, Kornek G, et al (1993) Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 306:752–755PubMedGoogle Scholar
  145. Schimanski CC, Linnemann U, Galle PR, et al (2003) Hepatic disseminated tumor cells in colorectal cancer UICC stage 4 patients: prognostic implications. Int J Oncol 23:791–796PubMedGoogle Scholar
  146. Seifert JK, Morris DL (1998) Cryotherapy of the resection edge after liver resection for colorectal cancer metastases. Aust N Z J Surg 68:725–728PubMedGoogle Scholar
  147. Seifert JK, Staupendahl D, Junginger T (1997) Repeat interventions in metastases. Chirurg 68:247–254CrossRefPubMedGoogle Scholar
  148. Shen P, Hoffman A, Howerton R, et al (2002) Cryosurgery of close or positive margins after hepatic resection for primary and metastatic hepatobiliary malignancies. Am Surg 68:695–703PubMedGoogle Scholar
  149. Shibata T, Niinobu T, Ogata N, et al (2000) Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 89:276–284CrossRefPubMedGoogle Scholar
  150. Sigurdson ER, Ridge JA, Kemeny N, et al (1987) Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol 5:1836–1840PubMedGoogle Scholar
  151. Siperstein AE, Rogers JS, Machi J, et al (2002) Long-term follow-up of patients undergoing radiofrequency thermal ablation of primary metastatic liver tumors: A multi-center study. ACS 88th Annual Clinical Congress, 9-10-2002, San Francisco, CAGoogle Scholar
  152. Solbiati L, Livraghi T, Goldberg SN, et al (2001) Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221:159–166PubMedGoogle Scholar
  153. Staib L, Link KH, Beger HG (2001) Toxicity and effects of adjuvant therapy in colon cancer: results of the German prospective controlled randomized multicenter trial FOGT 1. J Gastrointest Surg 5:275–281CrossRefPubMedGoogle Scholar
  154. Steele G, Bleday R, Mayer RJ, et al (1991) A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol 9:1105–1112PubMedGoogle Scholar
  155. Sugihara K, Hojo K, Moriya Y, et al (1993) Pattern of recurrence after hepatic resection for colorectal metastases. Br J Surg 80:1032–1035PubMedGoogle Scholar
  156. Tanaka K, Adam R, Shimada H, et al (2003) Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 90:963–969PubMedGoogle Scholar
  157. Taylor FW (1962) Cancer of the colon and rectum: a study of routes of metastases and death. Surgery 52:305–308PubMedGoogle Scholar
  158. Thirion P, Wolmark N, Haddad E, et al (1999) Survival impact of chemotherapy in patients with colorectal metastases confined to the liver: a re-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analyses. Meta-analysis Group In Cancer. Ann Oncol 10:1317–1320CrossRefPubMedGoogle Scholar
  159. Tono T, Hasuike Y, Ohzato H, et al (2000) Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: a randomized study. Cancer 88:1549–1556CrossRefPubMedGoogle Scholar
  160. Topal B, Kaufman L, Aerts R, et al (2003) Patterns of failure following curative resection of colorectal liver metastases. Eur J Surg Oncol 29:248–253CrossRefPubMedGoogle Scholar
  161. Tsujitani S, Watanabe A, Kakeji Y, et al (1991) Hepatic recurrence not prevented with low-dosage long-term intraportal 5-FU infusion after resection of colorectal liver metastasis. Eur J Surg Oncol 17:526–529PubMedGoogle Scholar
  162. Vaillant JC, Balladur P, Nordlinger B, et al (1993) Repeat liver resection for recurrent colorectal metastases. Br J Surg 80:340–344PubMedGoogle Scholar
  163. van Ooijen B, Wiggers T, Meijer S, et al (1992) Hepatic resections for colorectal metastases in The Netherlands. A multi-institutional 10-year study. Cancer 70:28–34PubMedGoogle Scholar
  164. van Riel JM, van Groeningen CJ, Kedde MA, et al (2002) Continuous administration of irinotecan by hepatic arterial infusion: a phase I and pharmacokinetic study. Clin Cancer Res 8:405–412PubMedGoogle Scholar
  165. Vlems FA, Diepstra JH, Punt CJ, et al (2003) Detection of disseminated tumour cells in blood and bone marrow samples of patients undergoing hepatic resection for metastasis of colorectal cancer. Br J Surg 90:989–995CrossRefPubMedGoogle Scholar
  166. Vogel KM (2000) Der natürliche Verlauf von Lebermetastasen kolorektaler Karzinome in abhängigkeit von mehreren prognostischen Kriterien. Medizinische Fakultät der Unversität Ulm, Ulm, GermanyGoogle Scholar
  167. Vogl TJ, Mack MG, Roggan A (2000) Magnetresonanztomographisch gesteuerte laserinduzierte Theramographie von Lebermetastasen. Dtsch Ärztebl 37:2039–2044Google Scholar
  168. Vogl TJ, Straub R, Eichler K, et al (2004) Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy — local tumor control rate and survival data. Radiology 230:450–458PubMedGoogle Scholar
  169. Wadler S, Schwartz EL, Goldman M, et al (1989) Fluorouracil and recombinant alpha-2a-interferon: An active regimen against advanced colorectal carcinoma. J Clin Oncol 7:1769–1775PubMedGoogle Scholar
  170. Wagner JG, Gyves JW, Stetson P, et al (1986) Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusion in cancer patients. Cancer Res 46:1499–1506PubMedGoogle Scholar
  171. Wang JY, Chiang JM, Jeng LB, et al (1996) Resection of liver metastases from colorectal cancer: are there any truly significant clinical prognosticators? Dis Colon Rectum 39:847–851PubMedGoogle Scholar
  172. Wein A, Riedel C, Bruckl W, et al (2003) Neoadjuvant treatment with weekly high-dose 5-fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer. Oncology 64:131–138CrossRefPubMedGoogle Scholar
  173. Weiss SM, Skibber JM, Mohiuddin M, et al (1985) Rapid intra-abdominal spread of pancreatic cancer. Influence of multiple operative biopsy procedures. Arch Surg 120:415–416PubMedGoogle Scholar
  174. Weiss L, Ward PM (1991) Metachronous and synchronous seeding of target-organs in the mouse, after paracecal injection of colon-26 cancer cells: Is it relevant to human metastatic colorectal cancer? Reg Cancer Treat 4:55–59Google Scholar
  175. Witte RS, Cnaan A, Mansour EG, et al (2001) Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intraabdominal metastasis after undergoing resection for colorectal carcinoma. Cancer 91:1020–1028CrossRefPubMedGoogle Scholar
  176. Yamaguchi J, Komuta K, Matsuzaki S, et al (2002a) Mode of infiltrative growth of colorectal liver metastases is a useful predictor of recurrence after hepatic resection. World J Surg 26:1122–1125CrossRefPubMedGoogle Scholar
  177. Yamaguchi J, Sakamoto I, Fukuda T, et al (2002b) Computed tomographic findings of colorectal liver metastases can be predictive for recurrence after hepatic resection. Arch Surg 137:1294–1297PubMedGoogle Scholar
  178. Yan DB, Clingan P, Morris DL (2003) Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many? Cancer 98:320–330CrossRefPubMedGoogle Scholar
  179. Yedibela S, Jawad MK, Graz V, et al (2004) Vergleich der Indikation und Ergebnisse nach Resektion nicht-kolorektaler Lebermetastasen an der Chrirugischen Universitätsklinik Erlangen-Nuernberg bei 162 Patienten zwischen 1972 und 2001. 121. Kongress der Deutschen Gesellschaft für Chirurgie, 27–30 April, ICC, BerlinGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Karl Heinrich Link
    • 1
  • Volker Apell
    • 1
  • Matthias Holtappels
    • 1
  • Karim Zayed
    • 1
  • Tolga Atilla Sagban
    • 1
  • Matthias Mörschel
    • 1
  • Thomas Friedrich Weigel
    • 1
  • Klaus Tischbirek
    • 2
  • Klaus Maria Josten
    • 3
  • Ralf Thimm
    • 4
  • Ludger Staib
    • 5
  1. 1.Surgical CenterAsklepios Paulinen Klinik (APK) and Asklepios Tumortreatment Center Rhein-Main (ATC)WiesbadenGermany
  2. 2.Department Medical Oncology and GastroenterologyAsklepios Paulinen Klinik (APK) and Asklepios Tumortreatment Center Rhein-Main (ATC)WiesbadenGermany
  3. 3.Interdisciplinary Outpatient OncologyAsklepios Paulinen Klinik (APK) and Asklepios Tumortreatment Center Rhein-Main (ATC)WiesbadenGermany
  4. 4.Department of RadiologyAsklepios Paulinen Klinik (APK) and Asklepios Tumortreatment Center Rhein-Main (ATC)WiesbadenGermany
  5. 5.Department of Surgery I and Ulm Cancer CenterUniversity of UlmUlmGermany

Personalised recommendations